NeoChord Device Could Herald New Approach to Mitral Valve Repair

Approximately 250,000 new diagnoses of MR are made each year, but only about 50,000 patients undergo surgery to fix the problem.

Read more »

CardiAQ Valve Technologies Announces New Data, New Board Members

CVT’s system, currently under development, is the first self-conforming and self-anchoring technology for transcatheter mitral valve implantation (TVMI).

Read more »

First Patient Successfully Treated With Algisyl-LVR Device

Symphony Medical, a developer of novel biopolymer technologies for cardiac disorders, has successfully used its flagship Algisyl-LVR technology to treat their first human patient.

Read more »